New combo pill aims to slash dangerous blood fats in High-Risk patients
NCT ID NCT03540355
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a drug called Cipros 20 in 406 adults with dyslipidemia (abnormal levels of fats in the blood) who also had high or very high heart disease risk. The goal was to see if it lowers triglycerides and LDL cholesterol more effectively than current options. Participants took the drug or a placebo for a period, and researchers measured changes in blood fat levels and tracked any side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSLIPIDEMIAS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Allergisa
Campinas, São Paulo, Brazil
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A diet designed for puerto rico: can traditional foods fight heart disease and diabetes?
- Can a smartphone app help lower bad cholesterol?
- Heart drug showdown: which statin spares your blood sugar?
- Aerobic exercise may tame multiple chronic conditions in postmenopausal women
- Bee product may boost health in oral cancer survivors
- Could AI help pharmacists give better advice?